Cargando…
Antiarrhythmic Properties of Ranolazine: Inhibition of Atrial Fibrillation Associated TASK-1 Potassium Channels
Background: Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia and one of the major causes of cardiovascular morbidity and mortality. Despite good progress within the past years, safe and effective treatment of AF remains an unmet clinical need. The anti-anginal agent ranolazin...
Autores principales: | Ratte, Antonius, Wiedmann, Felix, Kraft, Manuel, Katus, Hugo A., Schmidt, Constanze |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6988797/ https://www.ncbi.nlm.nih.gov/pubmed/32038227 http://dx.doi.org/10.3389/fphar.2019.01367 |
Ejemplares similares
-
Current Drug Treatment Strategies for Atrial Fibrillation and TASK-1 Inhibition as an Emerging Novel Therapy Option
por: Kraft, Manuel, et al.
Publicado: (2021) -
N-Glycosylation of TREK-1/hK(2P)2.1 Two-Pore-Domain Potassium (K(2P)) Channels
por: Wiedmann, Felix, et al.
Publicado: (2019) -
N-glycosylation–dependent regulation of hK(2P)17.1 currents
por: Wiedmann, Felix, et al.
Publicado: (2019) -
Pharmacologic TWIK‐Related Acid‐Sensitive K+ Channel (TASK‐1) Potassium Channel Inhibitor A293 Facilitates Acute Cardioversion of Paroxysmal Atrial Fibrillation in a Porcine Large Animal Model
por: Wiedmann, Felix, et al.
Publicado: (2020) -
Antiarrhythmic Effect of Ranolazine in Combination with Selective NCX-Inhibition in an Experimental Model of Atrial Fibrillation
por: Wolfes, Julian, et al.
Publicado: (2020)